1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Vin II: new trials by email Literature Review of Vin II trials Research Report on Vin II
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Cervical Cancer, Genital Wart | Phase 3 | Terminated | Shanghai Bovax Biotechnology Co., Ltd. | 3131 | 2022-12-09 | 2023-07-21 |
Condylomata Acuminata (1) · Uterine Cervical Neoplasms (1)
Communicable Diseases (1) · DNA Virus Infections (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Infections (1) · Neoplasms (1) · Neoplasms by Site (1) · Papillomavirus Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sexually Transmitted Diseases (1)
Shanghai Bovax Biotechnology Co., Ltd. (1)
China (1)